<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02570724</url>
  </required_header>
  <id_info>
    <org_study_id>5204</org_study_id>
    <nct_id>NCT02570724</nct_id>
  </id_info>
  <brief_title>HES Patch Versus Blood Patch</brief_title>
  <official_title>Clinical Effect and Cerebral Vasoconstriction Induced After Epidural Blood Patch Versus Epidural Hydroxyethyl Starch Patch in Patients With Headache Due to Intracranial Hypotension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The injection of autologous blood Blood Patch (BP) into the epidural space is the standard
      treatment for headache associated with intracranial hypotension. It provokes cerebral
      vasoconstriction. It is cons-indicated in a number of situations (HIV positive, fever,
      sepsis, leukemia). The purpose of this study is to evaluate another technique using a patch
      made by injecting an epidural hydroxyethylstarch solution (HES 130, 0.4, 6%) instead of blood
      patch. This alternative technique is simple to implement and does not have some of the
      specific blood pressure contra-indications. The study aims at comparing the &quot;Blood Patch&quot;
      group versus the &quot;HES Patch&quot; in terms of clinical efficacy , tolerance, satisfaction of the
      anesthetist, ease of implementation and effect of the injection of epidural anesthesia on
      cerebral blood flow within 24 hours.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variation of the pulsatility index (PI) of the middle cerebral artery transcranial Doppler</measure>
    <time_frame>36 hours</time_frame>
    <description>Compare the effect of epidural injection of autologous blood (Blood Patch) versus injection of a colloid (HES Voluven ®) on cerebral blood flow.
this study aims at observing the variation of the pulsatility index (PI) of middle cerebral artery observed by a transcranial Doppler between T0 and 30 minutes after the patch is administered.
The BP or HEA treatment will be considered equivalent if the proportion of clinical failures and side effects do not differ by more than 5%.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Intracranial Hypotension</condition>
  <arm_group>
    <arm_group_label>Blood Patch arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard of care arm: injection of autologous blood approximately 40 mL of blood sample into the epidural space at a rate of 1 ml / about 5 seconds.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug: injection of HES &quot; Voluven® &quot; patch arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug: injection of HES &quot; Voluven® &quot; into the epidural space of 15 to 30 ml at a rate of 1 ml / about 5 seconds</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>injection of HES &quot; Voluven® &quot;</intervention_name>
    <description>Injection into the epidural space of 15 to 30 ml Voluven ® at a rate of 1 ml / about 5 seconds.</description>
    <arm_group_label>Drug: injection of HES &quot; Voluven® &quot; patch arm</arm_group_label>
    <other_name>HYDROXYETHYL STARCH</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood patch</intervention_name>
    <arm_group_label>Blood Patch arm</arm_group_label>
    <other_name>injection of autologous blood</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects older than 18 years.·

          -  Subjects with an intracranial hypertension syndrome secondary to an epidural, spinal
             or lumbar puncture (and therefore presumed iatrogenic) with a sub arachnoid space or
             subjects with intracranial hypertension syndrome of primitive origin requiring
             treatment with epidural Patch ·

          -  subjects with a temporal window of sufficient quality to carry out the transcranial
             Doppler ·

          -  Subjects haven read the informed consent, signed and dated prior to the start of any
             proceedings related to the tial·

          -  Subjects affiliated to health insurance·

          -  Subjects having been informed of the results of a prior medical consultation

        Exclusion Criteria:

          -  Subjects with a cons-indication to an epidural Patch:

          -  blood disorders constitutional or acquired coagulation with platelets

          -  Subjects under treatment with curative doses of antiplatelet drugs or anticoagulants

          -  subjects under shock and / or hypovolemia

          -  subjects under generalized sepsis or at the puncture site

          -  any other cons-indication to performing an epidural
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pierre DIEMUNSCH, MD, PHD</last_name>
    <phone>03 88 12 70 76</phone>
    <email>pierre-diemunsch@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antoine CHARTON, MD</last_name>
    <phone>03 88 12 70 76</phone>
    <email>antoine.charton@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service Anesthésie Réanimation Chirurgicale Hôpitaux Universitaires de Strasbourg, 1 avenue Molière</name>
      <address>
        <city>Strasbourg</city>
        <state>Strasbourg cedex</state>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoine Charton, MD</last_name>
      <phone>03 88 12 70 75</phone>
    </contact>
    <investigator>
      <last_name>CHARTON ANTOINE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>PIERRE DIEMUNSCH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 29, 2015</study_first_submitted>
  <study_first_submitted_qc>October 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2015</study_first_posted>
  <last_update_submitted>September 7, 2017</last_update_submitted>
  <last_update_submitted_qc>September 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Intracranial Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

